Clinical Trial Update: Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Velcade, Melphalan, Prednisone and Thalidomide versus Velcade, Melphalan, Prednisone in patients with multiple myeloma has completed enr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED